Fundraising FoxSonaspharma
1 known investors
Find your way into Sonaspharma
Sign up to see every warm intro you have to Sonaspharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Sonaspharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Sonas Pharma is a biotech startup developing endocannabinoid-based therapies, focused on engineering CB1R-targeted molecules to treat epilepsy and metabolic diseases such as obesity. Its drug development approach centers on receptor selectivity, peripheral restriction, and optimized pharmacological and safety properties beyond first-generation cannabinoid drugs like CBD.
Investors · 1
Frequently asked questions
- What does Sonaspharma do?
- Sonas Pharma is a biotech startup developing endocannabinoid-based therapies, focused on engineering CB1R-targeted molecules to treat epilepsy and metabolic diseases such as obesity. Its drug development approach centers on receptor selectivity, peripheral restriction, and optimized pharmacological and safety properties beyond first-generation cannabinoid drugs like CBD.
- Who are Sonaspharma's investors?
- Sonaspharma's investors include Clarendon Fund Managers Ltd..